Are β-blockers necessary for patients with heart failure with preserved ejection fraction? PURSUIT-HFpEF registry

In HFpEF patients without AF or IHD, β-blocker use was associated with higher mortality-related risk, indicating that routine β-blocker use in this subgroup should be interpreted with caution.